Skip to main content
. Author manuscript; available in PMC: 2008 Oct 29.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2007 Oct 19;35(3):570–578. doi: 10.1007/s00259-007-0549-4

Table 2.

Creatine kinase assay (U/l per g, mean±SEM)

Baseline Treatment 1 Treatment 2 30 min p tracer 60 min p tracer 90 min p tracer 120 min p tracer
Control (n=6) 6.3±1.7 5.5±0.9 4.3±0.7 6.4±1.2 5.0±0.9
Stunned (n=6) 10.4±1.5 4.5±0.8 3.3±0.8 4.8±0.9 6.0±1.4
IR 60 (n=6) 8.9±0.7 39.8±4.2* 19.1±3.5* 14.1±2.0* 12.6±1.7 10.8±1.2 10.6±1.1
Calcium (n=5) 5.4±1.1 260.4±52.9* 522.3±56.3* 7.9±1.3 2.7±0.6 2.9±0.8 2.1±0.6
*

p<0.05 compared with baseline